These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2199202)

  • 1. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
    Batch J; Ma A; Bird D; Noble R; Charles B; Ravenscroft P; Cameron D
    Eur J Clin Pharmacol; 1990; 38(5):465-7. PubMed ID: 2199202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics.
    Brogard JM; Pinget M; Dorner M
    Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics.
    Couturier E
    Diabetes Res Clin Pract; 1985-1986 Mar; 1(6):343-7. PubMed ID: 3915271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.
    Ma A; Kamp M; Bird D; Howlett V; Cameron DP
    Aust N Z J Med; 1989 Feb; 19(1):44-9. PubMed ID: 2669710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
    Procacci V; Giovine A; Roberto MG; Di Reda N; Lasorsa G; Vendemiale G; Stufano N; Altomare E
    Boll Soc Ital Biol Sper; 1988 Sep; 64(9):817-24. PubMed ID: 3072977
    [No Abstract]   [Full Text] [Related]  

  • 7. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
    Hosker JP; Rudenski AS; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1989 Aug; 38(8):767-72. PubMed ID: 2668699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.
    Chazan AC; Gomes MB
    Braz J Med Biol Res; 2001 Jan; 34(1):49-56. PubMed ID: 11151028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of timing on gliclazide absorption and action.
    Ishibashi F; Takashina S
    Hiroshima J Med Sci; 1990 Mar; 39(1):7-9. PubMed ID: 2373640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prolonged gliclazide therapy in non-insulin dependent diabetic subjects.
    Donatelli M; Sinagra D; Russo V; Bucalo ML; Giardina E; Cerasola GA; Bompiani G
    Pharmatherapeutica; 1985; 4(2):69-75. PubMed ID: 3903780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gliclazide on non-insulin dependent diabetes mellitus.
    Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D
    Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Wajchenberg BL; Santomauro AT; Porrelli RN
    Diabetes Res Clin Pract; 1993 May; 20(2):147-54. PubMed ID: 8375268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
    Matthews DR; Boland O
    Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
    Ligtenberg JJ; Reitsma WD; van Haeften TW
    Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
    Scheen AJ; Lefebvre PJ; Luyckx AS
    Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acute and chronic hypoglycemic action of gliclazide.
    da Tos V; Maran A; Vigili de Kreutzenberg S; Marchetto S; Tadiotto F; Bettio M; Marescotti MC; Tiengo A; Del Prato S
    Acta Diabetol; 2000; 37(4):201-6. PubMed ID: 11450504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.